Maternal opioid treatment: Human experimental research (mother)-approach, issues and lessons learned

Addiction

Volumn 107, Issue SUPPL.1, 2012, Pages 28-35

  Jones, Hendrée E ^a,b   Fischer, Gabriele ^c   Heil, Sarah H ^d   Kaltenbach, Karol ^e   Martin, Peter R ^f   Coyle, Mara G ^g   Selby, Peter ^h   Stine, Susan M ⁱ   O'Grady, Kevin E ^j   Arria, Amelia M ^k  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RTI INTERNATIONAL   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY OF VERMONT   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f VANDERBILT UNIVERSITY   (United States)

^g BROWN UNIVERSITY   (United States)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF MARYLAND   (United States)

^k UNIVERSITY OF MARYLAND   (United States)

more..

Author keywords

Alcohol and other drug use; Opioid dependence; Pharmacological treatment; Pregnancy

Indexed keywords

BUPRENORPHINE; NARCOTIC ANTAGONIST;

CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; FEMALE; HUMAN; METHODOLOGY; MULTICENTER STUDY; NEWBORN; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PATIENT SELECTION; PREGNANCY; PREGNANCY COMPLICATION; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME; UNITED STATES; WITHDRAWAL SYNDROME;

BUPRENORPHINE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT, NEWBORN; NARCOTIC ANTAGONISTS; NEONATAL ABSTINENCE SYNDROME; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT SELECTION; PREGNANCY; PREGNANCY COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; UNITED STATES;

EID: 84868155663     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2012.04036.x     Document Type: Article

References (25)

1. Jones H. E., Kaltenbach K., Heil S. H., Stine S. M., Coyle M. G., Arria A. M. etal. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010; 363: 2320-2331.
2. Jones H. E., Heil S. H., Baewert A., Arria A. M., Kaltenbach K., Martin P. R. etal. Buprenorphine treatment of opioid-dependent pregnant women: a comprehesive review. Addiction 2012; 107 (Suppl. 1): 5-27.
3. Jones H. E., Johnson R. E., Jasinski D. R., Milio L. Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone. Drug Alcohol Depend 2005; 78: 33-38.
4. Jones H. E., Johnson R. E., Jasinski D. R., O'Grady K. E., Chisholm C. A., Choo R. E. etal. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend 2005; 79: 1-10.
5. Felice M. E., Feinstein R. A., Fisher M. M., Kaplan D. W., Olmedo L. F., Rome E. S. etal. Adolescent pregnancy-current trends and issues: 1998 American Academy of Pediatrics Committee on Adolescence, 1998-1999. Pediatrics 1999; 103: 516-520.
6. Jolly M., Sebire N., Harris J., Robinson S., Regan L. The risks associated with pregnancy in women aged 35 years or older. Hum Reprod 2000; 15: 2433-2437.
7. Jolly M. C., Sebire N., Harris J., Robinson S., Regan L. Obstetric risks of pregnancy in women less than 18 years old. Obstet Gynecol 2000; 96: 962-966.
8. First M. B., Spitzer R. L., Gibbon M., Williams J. B. Structured Clinical Interview for DSM-IV Axis I Disorders. New York: New York State Psychiatric Institute; 1996.
9. Department of Health and Human Services. Federal Guidelines for Opioid Agonists. Washington, DC: Author; 2001.
10. Schmid M., Kuessel L., Klein K., Metz V., Fischer G., Krampl-Bettelheim E. First-trimester fetal heart rate in mothers with opioid addiction. Addiction 2010; 105: 1265-1268.
11. Levy M., Spino M. Neonatal withdrawal syndrome: associated drugs and pharmacologic management. Pharmacotherapy 1993; 13: 202-211.
12. Theis J. G., Selby P., Ikizler Y., Koren G. Current management of the neonatal abstinence syndrome: a critical analysis of the evidence. Biol Neonate 1997; 71: 345-356.
13. Kintz P. Buprenorphine-related deaths. In: Kintz P., Marquet P., editors. Buprenorphine Therapy of Opiate Addiction. Totowa: Humana Press; 2002, p. 109-118.
14. Fudala P. J., Bridge T. P., Herbert S., Williford W. O., Chiang C. N., Jones K. etal. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med 2003; 349: 949-958.
15. Brunton P. J., Meddle S. L., Ma S., Ochedalski T., Douglas A. J., Russell J. A. Endogenous opioids and attenuated hypothalamic-pituitary-adrenal axis responses to immune challenge in pregnant rats. J Neurosci 2005; 25: 5117-5126.
16. Douglas A. J., Meddle S. L., Toschi N., Bosch O. J., Neumann I. D. Reduced activity of the noradrenergic system in the paraventricular nucleus at the end of pregnancy: implications for stress hyporesponsiveness. J Neuroendocrinol 2005; 17: 40-48.
17. Johnson R. E., Jaffe J. H., Fudala P. J. A controlled trial of buprenorphine treatment for opioid dependence. JAMA 1992; 267: 2750-2755.
18. Ling W., Wesson D. R., Charuvastra C., Klett C. J. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch Gen Psychiatry 1996; 53: 401-407.
19. Strain E. C., Moody D. E., Stoller K. B., Walsh S. L., Bigelow G. E. Bioavailability of buprenorphine solution versus tablets during chronic dosing in opioid-dependent subjects. Drug Alcohol Depend 2002; 66: S176.
20. Lussier J. P., Heil S. H., Mongeon J. A., Badger G. J., Higgins S. T. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006; 101: 192-203.
21. Finnegan L. P., Kaltenbach K. Neonatal abstinence syndrome. In: Hoekelman R. A., Friedman S. B., Nelson N. M., Seidel H. M., editors. Primary Pediatric Care, 2nd edn. St Louis: Mosby; 1992, p. 1367-1378.
22. D'Apolito K. A Scoring System for Assessing Neonatal Abstinence Syndrome [Video Tapes]. Seattle: University of Washington, School of Nursing; 1994.
23. Lester B. M., Tronick E. Z. History and description of the Neonatal Intensive Care Unit Network Neurobehavioral Scale. Pediatrics 2004; 113: 634-640.
24. Fischer G., Ortner R., Rohrmeister K., Jagsch R., Baewert A., Langer M. etal. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction 2006; 101: 275-281.
25. McLellan A. T., Kushner H., Metzger D., Peters R., Smith I., Grissom G. etal. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9: 199-213.